Axonics, Inc. (AXNX)

Axonics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	248.47	117.53	238.85	220.88	241.18	171.08
Short-Term Investments	100.16	240.15	118.37	0	0	12.59
Cash & Cash Equivalents	348.63	357.67	357.21	220.88	241.18	183.67
Cash Growth	-2.36%	0.13%	61.72%	-8.42%	31.31%	16.60%
Receivables	50.53	57.24	44.82	29.04	18.27	7.88
Inventory	93.19	79.94	55.77	64.95	63.06	15.66
Other Current Assets	-10.32	-3.44	7.28	6.45	5.44	4.47
Total Current Assets	482.03	491.42	465.08	321.32	327.95	211.68
Property, Plant & Equipment	17.04	10.76	6.8	6.92	6.33	3.05
Goodwill and Intangibles	176.97	180.79	180.67	211.98	0.2	0.31
Other Long-Term Assets	39.53	36.95	6.81	7.73	7.74	4.78
Total Long-Term Assets	233.53	228.5	194.28	226.63	14.26	8.14
Total Assets	715.56	719.92	659.35	547.95	342.21	219.82
Accounts Payable	15.77	18.45	9.07	7.65	10.66	5.88
Current Debt	1.46	1.78	1.56	1.37	22.39	0.6
Other Current Liabilities	31.16	25.59	54.62	17.85	12.63	5.55
Total Current Liabilities	48.39	45.82	65.25	26.87	45.68	12.03
Long-Term Debt	30.15	25.84	7.56	9.05	9.15	24.79
Other Long-Term Liabilities	9.92	10.7	16.41	29.59	0	0
Total Long-Term Liabilities	40.08	36.54	23.97	38.64	9.15	24.79
Total Liabilities	88.46	82.36	89.21	65.51	54.84	36.82
Total Debt	31.61	27.62	9.12	10.42	31.54	25.39
Debt Growth	261.88%	202.92%	-12.49%	-66.97%	24.25%	7.98%
Retained Earnings	-399.46	-380.35	-374.26	-314.57	-234.5	-179.58
Comprehensive Income	-17.02	-15.87	-25.15	-6.56	-0.43	-0.43
Shareholders' Equity	627.1	637.56	570.14	482.44	287.37	183
Net Cash / Debt	317.02	330.06	348.09	210.46	209.64	158.29
Net Cash / Debt Growth	-8.99%	-5.18%	65.40%	0.39%	32.44%	18.11%
Net Cash Per Share	6.22	6.72	7.46	4.89	5.67	5.54
Working Capital	433.64	445.61	399.83	294.45	282.26	199.65
Book Value Per Share	12.31	12.99	12.21	11.20	7.77	6.41

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).